Free Trial

Stocks rise in morning trading; S&P 500 hovers above record

In this Nov. 23, 2020 file photo, a street sign is displayed at the New York Stock Exchange in New York. Stocks are off to a mostly higher start on Wall Street, keeping several indexes near record highs, but weakness in some Big Tech shares kept the gains in check (AP Photo/Seth Wenig, File)

NEW YORK (AP) — U.S. stocks are edging higher in morning trading Wednesday and hovering above their recent record highs as coronavirus vaccines move closer to distribution and Washington ramps up stimulus talks.

A vaccine from Pfizer and German partner BioNTech, which is already in use in the U.K., is on track for a positive review and potential approval in the U.S. within the next week. The Food and Drug Administration will also consider a vaccine developed by Moderna later this month. The prospect for a vaccine is giving Wall Street hope that the economy is nearing a more direct path to a full recovery.

The S&P 500 rose 0.2%, putting it above its record of 3,702.25 set on Tuesday. The index is already up 2.5% this month following one of its best months in decades during November.

The Dow Jones Industrial Average was up 62 points, or 0.2%, at 30,236, as of 9:55 a.m. Eastern time, and the Nasdaq composite was 0.1% higher.

Companies that stand to benefit the most from a recovering economy were putting up solid gains. Walt Disney, which has seen attendance at its parks suffer amid the pandemic, rose 1.9%. Citigroup rose 2% as Treasury yields gained ground in a sign of optimism for the the economy.

The yield on the 10-year Treasury rose to 0.95% from 0.90% late Tuesday.

Utilities, real estate companies and other safe-play sectors lagged the broader market as investors shifted money into assets with more risk.

The market has been making gains as investors weigh the continued economic damage being inflicted by the virus against anticipation for a return to normalcy as vaccines start to move closer to approval and wider distribution. The recent surge in coronavirus cases and tighter restrictions on businesses over the last few weeks has again raised the importance of a vaccine for beaten down businesses.

But there could be more economic damage in store over the next few months and investors are still closely watching Washington for any developments on another shot of stimulus for people, businesses and state governments. Congress is still divided over the size and scope of any new package and the Trump administration has added to the potential plans with a new $916 billion proposal.

European markets made gains. France’s CAC 40 was up 0.2%, Germany’s DAX rose 0.8% and the FTSE 100 in London rose 0.4%. Asian markets mostly rose.

Should You Invest $1,000 in Walt Disney Right Now?

Before you consider Walt Disney, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Walt Disney wasn't on the list.

While Walt Disney currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Defense Stocks Under $10 With Massive Upside
NVIDIA: Another 200% Growth Ahead? (PLUS 2 Companies Riding Along)
3 Rising Stocks You’ll Want on Your Watchlist

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines